CHA AI Healthkare Co.,Ltd.(KR:025620)
â‚©4,825.00-30.00 (-0.62%)
KR:025620
CHA AI Healthkare Co.,Ltd. financials statements
â‚©4,825.00
At close:-30.00 (-0.62%)
Want to see KR:025620 full AI Analyst Report?
CHA AI Healthkare Co.,Ltd. (025620) Ratios
CHA AI Healthkare Co.,Ltd. Ratios
KR:025620's free cash flow for Q3 2026 was ₩-1.92B. For the 2026 fiscal year, KR:025620's free cash flow was increased by ₩0.00 and operating cash flow was ₩-1.92B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.49 | 1.43 | 2.27 | 3.48 | 1.40 |
| Quick Ratio | 1.40 | 1.13 | 1.87 | 3.21 | 1.12 |
| Cash Ratio | 1.16 | 0.23 | 0.58 | 1.64 | 0.43 |
| Solvency Ratio | 0.06 | -0.96 | -0.73 | -3.06 | -1.87 |
| Operating Cash Flow Ratio | -0.20 | -0.78 | -1.20 | -0.78 | -0.18 |
| Short-Term Operating Cash Flow Coverage | -0.23 | -1.62 | -4.68 | -2.34 | -0.48 |
| Net Current Asset Value | â‚© 15.93B | â‚© 3.46B | â‚© 10.22B | â‚© 15.53B | â‚© 6.94B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.14 | 0.06 | 0.06 | 0.11 |
| Debt-to-Equity Ratio | 0.41 | 0.18 | 0.07 | 0.07 | 0.14 |
| Debt-to-Capital Ratio | 0.29 | 0.15 | 0.07 | 0.06 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.46 | 1.31 | 1.21 | 1.16 | 1.34 |
| Debt Service Coverage Ratio | -0.23 | -2.08 | -3.99 | -10.65 | -1.81 |
| Interest Coverage Ratio | -7.11 | -44.32 | -78.83 | -16.46 | -10.44 |
| Debt to Market Cap | 0.15 | 0.27 | 0.10 | 0.15 | 0.12 |
| Interest Debt Per Share | 1738.52 | 1209.02 | 668.09 | 1146.69 | 3521.09 |
| Net Debt to EBITDA | 1.30 | -0.42 | 0.22 | 0.42 | -0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.27% | 46.90% | 49.60% | 14.48% | 4.78% |
| EBIT Margin | -105.24% | -52.06% | -59.50% | -127.81% | -121.07% |
| EBITDA Margin | -95.10% | -48.44% | -55.32% | -295.32% | -109.43% |
| Operating Profit Margin | -105.44% | -34.74% | -63.10% | -127.76% | -121.07% |
| Pretax Profit Margin | 18.71% | -52.84% | -42.19% | -312.37% | -239.87% |
| Net Profit Margin | 18.71% | -60.56% | -42.25% | -343.16% | -258.21% |
| Continuous Operations Profit Margin | 18.71% | -62.53% | -37.09% | -312.37% | -239.59% |
| Net Income Per EBT | 100.00% | 114.60% | 100.14% | 109.86% | 107.65% |
| EBT Per EBIT | -17.75% | 152.10% | 66.85% | 244.50% | 198.13% |
| Return on Assets (ROA) | 1.24% | -24.39% | -14.06% | -44.30% | -48.41% |
| Return on Equity (ROE) | 1.81% | -32.02% | -16.99% | -51.53% | -64.70% |
| Return on Capital Employed (ROCE) | -10.12% | -18.15% | -25.28% | -19.01% | -29.83% |
| Return on Invested Capital (ROIC) | -7.27% | -15.59% | -23.74% | -18.00% | -26.31% |
| Return on Tangible Assets | 1.25% | -24.51% | -14.15% | -44.45% | -53.25% |
| Earnings Yield | 0.70% | -55.26% | -29.21% | -127.96% | -63.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.44 | 3.28 | 15.89 | 0.67 | 19.78 |
| Payables Turnover | 5.27 | 123.73 | 5.30 | 16.34 | 6.06 |
| Inventory Turnover | 2.01 | 3.12 | 2.50 | 3.03 | 2.67 |
| Fixed Asset Turnover | 4.64 | 13.23 | 22.81 | 7.14 | 8.97 |
| Asset Turnover | 0.07 | 0.40 | 0.33 | 0.13 | 0.19 |
| Working Capital Turnover Ratio | 0.72 | 2.21 | 1.22 | 0.53 | -22.15 |
| Cash Conversion Cycle | 365.33 | 225.27 | 100.07 | 640.30 | 94.76 |
| Days of Sales Outstanding | 252.82 | 111.38 | 22.98 | 542.38 | 18.45 |
| Days of Inventory Outstanding | 181.81 | 116.84 | 146.02 | 120.27 | 136.51 |
| Days of Payables Outstanding | 69.30 | 2.95 | 68.93 | 22.34 | 60.19 |
| Operating Cycle | 434.63 | 228.22 | 169.00 | 662.64 | 154.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -368.70 | -1545.25 | -2263.31 | -1763.57 | -1188.76 |
| Free Cash Flow Per Share | -368.70 | -1599.81 | -2283.08 | -4590.56 | -3264.92 |
| Dividend Paid and CapEx Coverage Ratio | -1677970846.00 | -28.33 | -114.50 | -0.62 | -0.57 |
| Capital Expenditure Coverage Ratio | -1677970846.00 | -28.33 | -114.50 | -0.62 | -0.57 |
| Operating Cash Flow Coverage Ratio | -0.22 | -1.31 | -3.54 | -1.81 | -0.41 |
| Operating Cash Flow to Sales Ratio | -0.92 | -0.44 | -0.61 | -0.80 | -0.23 |
| Free Cash Flow Yield | -3.46% | -41.66% | -42.75% | -77.41% | -15.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 58.90 | -1.81 | -3.42 | -0.78 | -1.56 |
| Price-to-Sales (P/S) Ratio | 26.56 | 1.10 | 1.45 | 2.68 | 4.04 |
| Price-to-Book (P/B) Ratio | 2.57 | 0.58 | 0.58 | 0.40 | 1.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -28.91 | -2.40 | -2.34 | -1.29 | -6.31 |
| Price-to-Operating Cash Flow Ratio | -28.91 | -2.49 | -2.36 | -3.36 | -17.33 |
| Price-to-Earnings Growth (PEG) Ratio | -0.54 | -0.05 | 0.04 | 0.02 | -0.02 |
| Enterprise Value Multiple | -26.64 | -2.69 | -2.39 | -0.49 | -3.71 |
| Enterprise Value | 185.05B | 20.39B | 21.31B | 9.00B | 60.78B |
| EV to EBITDA | -26.64 | -2.69 | -2.39 | -0.49 | -3.71 |
| EV to Sales | 25.33 | 1.30 | 1.32 | 1.44 | 4.06 |
| EV to Free Cash Flow | -27.57 | -2.85 | -2.14 | -0.69 | -6.34 |
| EV to Operating Cash Flow | -27.57 | -2.95 | -2.16 | -1.81 | -17.41 |
| Tangible Book Value Per Share | 4101.44 | 6581.62 | 9103.13 | 14663.39 | 18011.74 |
| Shareholders’ Equity Per Share | 4144.23 | 6627.26 | 9180.69 | 14724.65 | 20359.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.18 | -0.00 | -0.48 | -0.00 |
| Revenue Per Share | 401.29 | 3503.64 | 3692.74 | 2211.24 | 5101.43 |
| Net Income Per Share | 75.09 | -2121.85 | -1560.00 | -7588.09 | -13172.56 |
| Tax Burden | 1.00 | 1.15 | 1.00 | 1.10 | 1.08 |
| Interest Burden | -0.18 | 1.02 | 0.71 | 2.44 | 1.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.72 | 0.70 | 1.07 | 1.32 | 1.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Income Quality | -4.91 | 0.73 | 1.45 | 0.23 | 0.09 |
Currency in KRW

